spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Taro Pharmaceutical Industries 

 HSMN NewsFeed - 29 Mar 2018
Crescita Announces Launch of Pliaglis in U.S.
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 4 Mar 2016
Cipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 10 Aug 2015
FDA Approves Taro’s Keveyis(TM) (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jul 2013
Taro Board Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Taro Receives FDA Approval for Granisetron Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Jul 2008
Taro and NextWave Announce Agreement to Co-Promote OVIDE(R) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
Taro Terminates Merger Agreement with Sun Pharmaceutical Industries Ltd.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2008
Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Mar 2008
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jan 2008
Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2007
Taro Receives Tentative Approval for Ranitidine Syrup ANDA
Biopharmaceuticals Gastroenterology Generics FDA
 HSMN NewsFeed - 13 Nov 2006
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
Biopharmaceuticals Regulatory Generics
 HSMN NewsFeed - 30 Oct 2006
Taro Receives Investigation Report
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2006
Taro Announces Filing Of ANDA For Oxcarbazepine Tablets 150, 300 And 600 MG
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 May 2006
Cardiva Medical, Inc. Completes $13.99 Million Series C Financing
Devices Interventional Venture Capital
Return to NewsFeed  

 Additional items found! 13

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 13 additional stories matching:
Taro Pharmaceutical Industries
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.